October 1, 2021
ECRI partners with FDA on safety of materials in medical devices
Editor's Note
ECRI, on September 30, announced a new partnership with the Food and Drug Administration (FDA) to improve the safety of medical devices through the use of safer materials.
ECRI is developing safety reports for materials commonly used in implantable medical devices and assessing their possible effects on patients over time.
The first four reports are available now on FDA.gov: magnesium, polypropylene, polyurethanes, and siloxanes.
Free Daily News
- Enhanced PPE among updates to improve instrument sterilization safety
- First transatlantic robotic thrombectomy performed
- Joint Commission releases National Performance Goal briefs
- Review on pneumatic tourniquet safety
- Coronary computed tomography angiography helps predict first coronary events
- Environment influences OR team performance
- Ambulatory shift transforming care models for high-acuity patients
- How to improve outpatient first case starts
- Engage anesthesia group to expand volume
- Ethical considerations for deploying AI in surgery
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement